GSK Paxil, AstraZeneca Prilosec Have New "Product By Process" Patents

 
• By The Pink Sheet

GlaxoSmithKline's most recent Paxil patent illustrates the latest wrinkle in patent infringement defense: "product by process" patents, attorney Robert Green (Leydig, Voit & Mayer, Chicago) told the National Association of Pharmaceutical Manufacturers bulk workshop March 20 in New York City.

More from Archive

More from Pink Sheet